UNSPSC 51311604: Setastine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H28ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6G3OCF528J, chemically known as 1h-azepine, 1-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)hexahydro- but generally known as setastine, which bears US NIH Compound Identifier 43082. European Medicines Agency schedules Setastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10500MIG.

UNSPSC 51311604 Setastine is a Commodity code under which state and local governments procure naloxone and drug deactivation systems for emergency medical response and community health initiatives. The code captures pharmaceutical and medical-device procurement tied to opioid-crisis mitigation and harm-reduction programs at the county and municipal level. Issuing bodies under this code include county health departments and public health authorities managing emergency medical supplies and community health operations.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract term was two years with an option for one-year renewal, and bidders were required to submit pricing electronically through the county's e-procurement portal by July 26, 2023, at 2:00 pm, with vendors responsible for all shipping and delivery costs. Compliance requirements included drug-free workplace certification, E-Verify authorization, workers' compensation and general liability insurance, and potential FEMA-related federal-compliance obligations such as adherence to the Clean Air Act and Federal Water Pollution Control Act. The procurement included a three-month probationary period permitting termination with or without cause.